Replimune Group Operating Expenses Growth & History (REPL)
Replimune Group's operating expenses was $319.9M for fiscal 2026.
View full Replimune Group company overviewReplimune Group annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $319.9M | $58.3M | +22.28% |
| 2025 | 2025-03-31 | $261.6M | $26.9M | +11.44% |
| 2024 | 2024-03-31 | $234.8M | $57.7M | +32.58% |
| 2023 | 2023-03-31 | $177.1M | $58.8M | +49.67% |
| 2022 | 2022-03-31 | $118.3M | $38.4M | +47.98% |
| 2021 | 2021-03-31 | $80.0M | $23.8M | +42.27% |
| 2020 | 2020-03-31 | $56.2M | $25.3M | +81.60% |
| 2019 | 2019-03-31 | $30.9M | $11.7M | +60.93% |
| 2018 | 2018-03-31 | $19.2M | $9.6M | +99.33% |
| 2017 | 2017-03-31 | $9.6M | — | — |
Replimune Group quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $68.2M | −$22.2M | −24.52% |
| Q4 2026 | 2026-03-31 | $73.3M | −$6.0M | −7.55% |
| Q3 2026 | 2025-12-31 | $71.9M | $5.8M | +8.86% |
| Q2 2026 | 2025-09-30 | $84.3M | $25.4M | +43.07% |
| Q1 2026 | 2025-06-30 | $90.4M | $33.1M | +57.62% |
| Q4 2025 | 2025-03-31 | $79.3M | $20.6M | +35.01% |
| Q3 2025 | 2024-12-31 | $66.0M | $9.5M | +16.77% |
| Q2 2025 | 2024-09-30 | $58.9M | −$4.9M | −7.70% |
| Q1 2025 | 2024-06-30 | $57.4M | $1.7M | +3.09% |
| Q4 2024 | 2024-03-31 | $58.8M | $5.8M | +10.87% |
| Q3 2024 | 2023-12-31 | $56.5M | $14.9M | +35.82% |
| Q2 2024 | 2023-09-30 | $63.8M | $22.3M | +53.52% |
| Q1 2024 | 2023-06-30 | $55.6M | $14.8M | +36.14% |
| Q4 2023 | 2023-03-31 | $53.0M | $21.0M | +65.67% |
| Q3 2023 | 2022-12-31 | $41.6M | $11.9M | +40.18% |
| Q2 2023 | 2022-09-30 | $41.6M | $12.3M | +42.17% |
| Q1 2023 | 2022-06-30 | $40.9M | $13.5M | +49.29% |
| Q4 2022 | 2022-03-31 | $32.0M | $9.8M | +44.19% |
| Q3 2022 | 2021-12-31 | $29.7M | $9.4M | +46.48% |
| Q2 2022 | 2021-09-30 | $29.2M | $9.6M | +48.74% |
| Q1 2022 | 2021-06-30 | $27.4M | $9.5M | +53.54% |
| Q4 2021 | 2021-03-31 | $22.2M | $5.8M | +35.39% |
| Q3 2021 | 2020-12-31 | $20.3M | $3.6M | +21.67% |
| Q2 2021 | 2020-09-30 | $19.7M | $7.4M | +60.62% |
| Q1 2021 | 2020-06-30 | $17.8M | $6.9M | +63.50% |
| Q4 2020 | 2020-03-31 | $16.4M | $8.6M | +109.37% |
| Q3 2020 | 2019-12-31 | $16.7M | $6.5M | +64.39% |
| Q2 2020 | 2019-09-30 | $12.2M | $5.1M | +72.33% |
| Q1 2020 | 2019-06-30 | $10.9M | $5.0M | +85.52% |
| Q4 2019 | 2019-03-31 | $7.8M | $761,000 | +10.77% |
| Q3 2019 | 2018-12-31 | $10.1M | $5.4M | +114.22% |
| Q2 2019 | 2018-09-30 | $7.1M | $2.8M | +66.92% |
| Q1 2019 | 2018-06-30 | $5.9M | $2.7M | +85.11% |
| Q4 2018 | 2018-03-31 | $7.1M | — | — |
| Q3 2018 | 2017-12-31 | $4.7M | — | — |
| Q2 2018 | 2017-09-30 | $4.3M | — | — |
| Q1 2018 | 2017-06-30 | $3.2M | — | — |
Replimune Group operating expenses trends
Over the last five fiscal years, Replimune Group's operating expenses increased from $80.0M to $319.9M, a change of $240.0M. The latest reported quarter, Q1 2027, shows $68.2M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Replimune Group source filings ↗